Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (104) 104
Paper (28) 28
Publication (23) 23
Book Review (2) 2
Book Chapter (1) 1
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (33) 33
experiment (30) 30
particle physics (27) 27
nuclear experiment (26) 26
physics (25) 25
high energy physics - experiment (23) 23
female (16) 16
high energy physics (16) 16
particle physics - experiment (15) 15
male (14) 14
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (13) 13
alice experiment (13) 13
nuclear physics (13) 13
aged (12) 12
matematikk og naturvitenskap: 400::fysikk: 430::kjerne- og elementærpartikkelfysikk: 431 [vdp] (12) 12
mathematics and natural scienses: 400::physics: 430::nuclear and elementary particle physics: 431 [vdp] (12) 12
middle aged (12) 12
risk factors (12) 12
[phys.nexp]physics [physics]/nuclear experiment [nucl-ex] (8) 8
index medicus (8) 8
nuclear physics - experiment (8) 8
anticoagulants - adverse effects (7) 7
anticoagulants - therapeutic use (7) 7
atrial fibrillation (7) 7
phenomenology (7) 7
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (6) 6
anticoagulants - administration & dosage (6) 6
cardiac & cardiovascular systems (6) 6
hadron-hadron scattering (6) 6
p-p collisions (6) 6
physics - high energy physics - experiment (6) 6
subatomic physics (6) 6
subatomär fysik (6) 6
[ phys.nexp ] physics [physics]/nuclear experiment [nucl-ex] (5) 5
adult (5) 5
aged, 80 and over (5) 5
atrial fibrillation - complications (5) 5
fibrinolytic agents - adverse effects (5) 5
atrial fibrillation - drug therapy (4) 4
d-dimer (4) 4
femoral artery (4) 4
fysik (4) 4
hematology (4) 4
hemorrhage - chemically induced (4) 4
natural sciences (4) 4
naturvetenskap (4) 4
pb-pb collisions (4) 4
peripheral vascular disease (4) 4
physical sciences (4) 4
physics - nuclear experiment (4) 4
physics, particles & fields (4) 4
stroke (4) 4
thromboembolism (4) 4
thrombosis - prevention & control (4) 4
warfarin - therapeutic use (4) 4
anticoagulation (3) 3
elementary particles, quantum field theory (3) 3
fibrin fibrinogen degradation products - analysis (3) 3
fibrinolytic agents - administration & dosage (3) 3
fibrinolytic agents - therapeutic use (3) 3
fibrinopeptide a (3) 3
heparin - adverse effects (3) 3
heparin, low-molecular-weight - therapeutic use (3) 3
incidence (3) 3
international normalized ratio (3) 3
physics and astronomy (3) 3
plasminogen activator inhibitor-1 (3) 3
popliteal artery (3) 3
practice guidelines as topic (3) 3
quantum field theories, string theory (3) 3
research (3) 3
risk assessment (3) 3
stroke - prevention & control (3) 3
surveys and questionnaires (3) 3
therapy (3) 3
thrombin (3) 3
thromboembolism - etiology (3) 3
thromboembolism - prevention & control (3) 3
thrombosis - blood (3) 3
thrombosis - drug therapy (3) 3
transluminal angioplasty (3) 3
usage (3) 3
venous thrombosis - prevention & control (3) 3
vitamin k - antagonists & inhibitors (3) 3
warfarin (3) 3
abridged index medicus (2) 2
angioplasty, balloon (2) 2
anticoagulants (2) 2
anticoagulants - pharmacokinetics (2) 2
arrhythmia (2) 2
atrial fibrillation - diagnosis (2) 2
atrial fibrillation - mortality (2) 2
blood coagulation factors (2) 2
blood loss, surgical (2) 2
bronchoalveolar lavage (2) 2
care and treatment (2) 2
classical and quantum gravitation, relativity theory (2) 2
clinical neurology (2) 2
contraindications (2) 2
denmark (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Svar
by Nielsen, Jørn Dalsgaard
Ugeskrift for Laeger, ISSN 0041-5782, 03/2017, Volume 179, Issue 10, p. 913
Journal Article
Details down arrow
2. Thromboprophylaxis in medical patients
by Nielsen, Jørn Dalsgaard
Ugeskrift for laeger, 09/2016, Volume 178, Issue 36
Venous Thromboembolism - prevention & control | Risk Assessment | Fibrinolytic Agents - therapeutic use | Humans | Risk Factors | Hospitalization | Heparin, Low-Molecular-Weight - therapeutic use | Venous Thromboembolism - diagnosis
Journal Article
Details down arrow
3. Tromboseprofylakse til medicinske patienter
by Nielsen, Jørn Dalsgaard
Ugeskrift for laeger, 09/2016, Volume 178, Issue 36
Journal Article
Details down arrow
4. Recurrence of venous thromboembolism
by Nielsen, Jørn Dalsgaard and Grove, Erik Lerkevang and Larsen, Torben Bjerregaard and Højen, Anette Asbjerg
Ugeskrift for laeger, 10/2018, Volume 180, Issue 20
Journal Article
Details down arrow
5. Recurrence of venous thromboembolism
by Nielsen, Jørn Dalsgaard and Grove, Erik Lerkevang and Larsen, Torben Bjerregaard and Højen, Anette Asbjerg
Ugeskrift for laeger, 10/2018, Volume 180, Issue 20A
Recurrence of venous thromboembolism (VTE) is seen in approximately one third of the patients after discontinuation of therapy with anticoagulants. The... 
Journal Article
Details down arrow
6. Perioperativ heparin-bridging er sjældent indiceret
by Nielsen, Jørn Dalsgaard and Münster, Anna-Marie Bloch and Husted, Steen Elkjær
Ugeskrift for Laeger, ISSN 0041-5782, 2016, Volume 178, Issue 12, pp. 1176 - 1179
Journal Article
Details down arrow
7. Perioperativ heparin-bridging er sjældent indiceret
by Nielsen, Jørn Dalsgaard and Münster, Anna-Marie Bloch and Husted, Steen Elkjær
Ugeskrift for laeger, 02/2016, Volume 178, Issue 9, p. V12150952
Journal Article
Details down arrow
8. Full Text Andrastins A-D, Penicillium roqueforti metabolites consistently produced in blue-mold-ripened cheese
by Nielsen, KF and Dalsgaard, PW and Smedsgaard, J and Larsen, TO
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, ISSN 0021-8561, 04/2005, Volume 53, Issue 8, pp. 2908 - 2913
This is the first finding of andrastins in blue cheese as well as any other sample type. Here, they were produced by the secondary starter culture Penicillium... 
Oasis MAX | SP FO-3929 | FOOD SCIENCE & TECHNOLOGY | SPE | BIOLOGICAL-ACTIVITIES | IDENTIFICATION | MASS-SPECTROMETRY | PERFORMANCE LIQUID-CHROMATOGRAPHY | Penicillium roqueforti | LC-MS | ANNATTO | blue-mold cheese | AGRICULTURE, MULTIDISCIPLINARY | PR TOXIN | CHEMISTRY, APPLIED | PROTEIN FARNESYLTRANSFERASE INHIBITORS | MYCOPHENOLIC-ACID | andrastin | MYCOTOXINS | Cheese - microbiology | Androstadienes - analysis | Enzyme Inhibitors | Androstenes - analysis | Mass Spectrometry | Alkyl and Aryl Transferases - antagonists & inhibitors | Androstenes - metabolism | Chromatography, High Pressure Liquid | Penicillium - metabolism | Androstadienes - metabolism | Farnesyltranstransferase | Andrastin | Blue-mold cheese
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Utilstrækkelig brug af venøs tromboseprofylakse på medicinske afdelinger i Danmark
by Kolodzeike, Piotr and Wille-Jørgensen, Peer and Rasmussen, Morten Schnack and Husted, Steen Elkjær and Nielsen, Jørn Dalsgaard
Ugeskrift for Laeger, ISSN 0041-5782, 02/2012, Volume 174, Issue 6, p. 333
Journal Article
Details down arrow
10. Behandling af heparininduceret immunbetinget trombocytopeni med argatroban
by Nielsen, Jørn Dalsgaard and Heslet, Lars
Ugeskrift for Laeger, ISSN 0041-5782, 02/2009, Volume 171, Issue 8, pp. 610 - 611
Journal Article
Details down arrow
11. Full Text Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation
by Raunso, Jakob and Selmer, Christian and Olesen, Jonas Bjerring and Charlot, Mette Gitz and Olsen, Anne-Marie S and Bretler, Ditte-Marie and Nielsen, Jorn Dalsgaard and Dominguez, Helena and Gadsboll, Niels and Kober, Lars and Gislason, Gunnar H and Torp-Pedersen, Christian and Hansen, Morten Lock
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue 15, pp. 1886 - 1892
It is presently unknown whether patients with atrial fibrillation (AF) are at increased risk of thrombo-embolic adverse events after interruption of warfarin... 
Warfarin | Rebound | Thrombo-embolism | Atrial fibrillation | PREDICTING STROKE | HYPERCOAGULABILITY | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | FOLLOW-UP | DISCONTINUATION | ANTIPLATELET | TASK-FORCE | ANTICOAGULANT-THERAPY | TERMINATION | WITHDRAWAL | Atrial Fibrillation - drug therapy | Humans | Risk Factors | Atrial Fibrillation - complications | Hospitalization - statistics & numerical data | Anticoagulants - therapeutic use | Male | Thromboembolism - etiology | Thromboembolism - mortality | Withholding Treatment | Cause of Death | Warfarin - therapeutic use | Atrial Fibrillation - mortality | Aged, 80 and over | Denmark - epidemiology | Female | Aged | Retrospective Studies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Monitoring novel anticoagulants dabigatron, rivaroxaban and apixaban using modified thrombelastography
by Artang, Ramin and Galloway, Gregg and Nielsen, Jorn Dalsgaard
Circulation, ISSN 0009-7322, 11/2015, Volume 132, Issue 19
Care and treatment | Usage | Arrhythmia | Electrophysiology | Anticoagulants (Medicine) | Dosage and administration | Hemorrhage | Risk factors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Vitamin K-antagonister og deres afløsere
by Nielsen, Jørn Dalsgaard
Ugeskrift for Laeger, ISSN 0041-5782, 03/2007, Volume 169, Issue 12, p. 1134
Journal Article
Details down arrow
14. Full Text Local pulmonary administration of factor viia (rFVIIa) in diffuse alveolar hemorrhage (DAH) - a review of a new treatment paradigm
by Heslet, Lars and Nielsen, Jørn Dalsgaard and Nepper-Christensen, Steen
Biologics: Targets and Therapy, ISSN 1177-5475, 2012, Volume 6, pp. 37 - 46
Elucidates the clinical aspects of alveolar haemorrhage. Develops a simple diagnostic algorithm in order to separate diffuse alveolar haemorrhage (DAH) from... 
New treatment recommendation | Diffuse alveolar hemorrhage | Blast lung injury | Bronchoalveolar lavage | Biologics | Diagnosis | Local pulmonary treatment | Algorithm | Hemosiderosis | Coagulation factor FVIIa | Treatment | Blood coagulation factors | Lungs | Hemorrhage | Diseases | Research | Drug therapy | Health aspects | Respiratory therapy | Respiratory distress syndrome | Mortality | local pulmonary treatment | new treatment recommendation | diffuse alveolar hemorrhage | biologics | blast lung injury | coagulation factor FVIIa | diagnosis | Review | bronchoalveolar lavage | hemosiderosis | algorithm
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Trombelastografi - Skal det laves og hvornår?
by Nielsen, Jørn Dalsgaard
Ugeskrift for Laeger, ISSN 0041-5782, 10/2006, Volume 168, Issue 41, p. 3505
Journal Article
Details down arrow
16. Argatroban treatment of heparin-induced immune-mediated thrombocytopenia
by Nielsen, Jørn Dalsgaard and Heslet, Lars
Ugeskrift for laeger, 02/2009, Volume 171, Issue 8, p. 610
Heparin-induced immune-mediated thrombocytopenia (HIT) is a life-threatening complication of heparin treatment. When HIT is clinically suspected, heparin... 
Fibrinolytic Agents - adverse effects | Pipecolic Acids - administration & dosage | Thrombocytopenia - drug therapy | Humans | Platelet Aggregation Inhibitors - administration & dosage | Pipecolic Acids - therapeutic use | Thrombocytopenia - chemically induced | Anticoagulants - adverse effects | Heparin - adverse effects | Platelet Aggregation Inhibitors - therapeutic use
Journal Article
Details down arrow
17. Full Text Meta-Analysis of Randomized Controlled Trials on Risk of Myocardial Infarction from the Use of Oral Direct Thrombin Inhibitors
by Artang, Ramin, MD and Rome, Eric, DO and Nielsen, Jørn Dalsgaard, MD and Vidaillet, Humberto J., MD
American Journal of Cardiology, The, ISSN 0002-9149, 2013, Volume 112, Issue 12, pp. 1973 - 1979
Dabigatran has been associated with greater risk of myocardial infarction (MI) than warfarin. It is unknown whether the increased risk is unique to dabigatran,... 
Cardiovascular | XIMELAGATRAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DABIGATRAN | THERAPY | VENOUS THROMBOEMBOLISM | STROKE PREVENTION | WARFARIN | NONVALVULAR ATRIAL-FIBRILLATION | ASPIRIN | SYSTEMIC EMBOLISM | ANTICOAGULATION | Myocardial Infarction - chemically induced | Amidines - adverse effects | beta-Alanine - adverse effects | Benzylamines - adverse effects | Atrial Fibrillation - drug therapy | Humans | Atrial Fibrillation - complications | Azetidines - adverse effects | Stroke - complications | Anticoagulants - therapeutic use | Dabigatran | Randomized Controlled Trials as Topic | Warfarin - therapeutic use | Antithrombins - adverse effects | Benzimidazoles - adverse effects | beta-Alanine - analogs & derivatives | Thrombin | Aspirin | Usage | Warfarin | Atrial fibrillation | Heart attack | Stroke (Disease) | Clinical trials | Cardiac arrhythmia | Anticoagulants | Stroke | Heart attacks | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Mindre dentoalveolær kirurgi på patienter i antitrombotisk behandling
by Nielsen, Jørn Dalsgaard and Lætgaard, Camilla Amtoft and Schou, Søren and Jensen, Simon Storgård
Ugeskrift for Laeger, ISSN 0041-5782, 04/2009, Volume 171, Issue 17, pp. 1407 - 1409
Journal Article
Details down arrow
19. Vitamin K antagonists and their successors. The Danish Society for Thrombosis and Hemostasis
by Nielsen, Jørn Dalsgaard and Dansk Selskab for Trombose og Haemostase
Ugeskrift for laeger, 03/2007, Volume 169, Issue 12, p. 1134
International Normalized Ratio | Vitamin K - antagonists & inhibitors | Anticoagulants - administration & dosage | Administration, Oral | Humans | Thrombosis - drug therapy | Thrombosis - prevention & control
Journal Article
Details down arrow
20. Den antitrombotisk behandlede patient
by Nielsen, Jørn Dalsgaard and Rasmussen, Hans Morten Schnack and Husted, Steen Elkjær
Ugeskrift for Laeger, ISSN 0041-5782, 12/2006, Volume 168, Issue 49, pp. 4296 - 4299
Journal Article
Details down arrow
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.